Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.
Serine protease granzyme B plays important roles in infections, autoimmunity, transplant rejection, and antitumor immunity. A triple-mutated granzyme B variant that encodes three amino substitutions (Q48R, P88A, and Y245H) has been reported to have altered biological functions. In the polymorphism r...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2011
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/49226eb624d5478481b10abfd0135fdc |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:49226eb624d5478481b10abfd0135fdc |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:49226eb624d5478481b10abfd0135fdc2021-11-18T06:47:26ZGenetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies.1932-620310.1371/journal.pone.0023827https://doaj.org/article/49226eb624d5478481b10abfd0135fdc2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21886827/?tool=EBIhttps://doaj.org/toc/1932-6203Serine protease granzyme B plays important roles in infections, autoimmunity, transplant rejection, and antitumor immunity. A triple-mutated granzyme B variant that encodes three amino substitutions (Q48R, P88A, and Y245H) has been reported to have altered biological functions. In the polymorphism rs8192917 (2364A>G), the A and G alleles represent wild type QPY and RAH mutant variants, respectively. In this study, we analyzed the impact of granzyme B polymorphisms on transplant outcomes in recipients undergoing unrelated HLA-fully matched T-cell-replete bone marrow transplantation (BMT) through the Japan Donor Marrow Program. The granzyme B genotypes were retrospectively analyzed in a cohort of 613 pairs of recipients with hematological malignancies and their unrelated donors. In patients with myeloid malignancies consisting of acute myeloid leukemia and myelodysplastic syndrome, the donor G/G or A/G genotype was associated with improved overall survival (OS; adjusted hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.41-0.89; P = 0.01) as well as transplant related mortality (TRM; adjusted HR, 0.48; 95% CI, 0.27-0.86, P = 0.01). The recipient G/G or A/G genotype was associated with a better OS (adjusted HR, 0.68; 95% CI, 0.47-0.99; P = 0.05) and a trend toward a reduced TRM (adjusted HR, 0.61; 95% CI, 0.35-1.06; P = 0.08). Granzyme B polymorphism did not have any effect on the transplant outcomes in patients with lymphoid malignancies consisting of acute lymphoid leukemia and malignant lymphoma. These data suggest that there is an association between the granzyme B genotype and better clinical outcomes in patients with myeloid malignancies after unrelated BMT.Luis J EspinozaAkiyoshi TakamiKatsuya NakataKayoko YamadaMakoto OnizukaTakakazu KawaseHiroshi SaoHideki AkiyamaKoichi MiyamuraShinichiro OkamotoMasami InoueTakahiro FukudaYasuo MorishimaYoshihisa KoderaShinji NakaoJapan Marrow Donor ProgramPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 8, p e23827 (2011) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Luis J Espinoza Akiyoshi Takami Katsuya Nakata Kayoko Yamada Makoto Onizuka Takakazu Kawase Hiroshi Sao Hideki Akiyama Koichi Miyamura Shinichiro Okamoto Masami Inoue Takahiro Fukuda Yasuo Morishima Yoshihisa Kodera Shinji Nakao Japan Marrow Donor Program Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. |
| description |
Serine protease granzyme B plays important roles in infections, autoimmunity, transplant rejection, and antitumor immunity. A triple-mutated granzyme B variant that encodes three amino substitutions (Q48R, P88A, and Y245H) has been reported to have altered biological functions. In the polymorphism rs8192917 (2364A>G), the A and G alleles represent wild type QPY and RAH mutant variants, respectively. In this study, we analyzed the impact of granzyme B polymorphisms on transplant outcomes in recipients undergoing unrelated HLA-fully matched T-cell-replete bone marrow transplantation (BMT) through the Japan Donor Marrow Program. The granzyme B genotypes were retrospectively analyzed in a cohort of 613 pairs of recipients with hematological malignancies and their unrelated donors. In patients with myeloid malignancies consisting of acute myeloid leukemia and myelodysplastic syndrome, the donor G/G or A/G genotype was associated with improved overall survival (OS; adjusted hazard ratio [HR], 0.60; 95% confidence interval [CI], 0.41-0.89; P = 0.01) as well as transplant related mortality (TRM; adjusted HR, 0.48; 95% CI, 0.27-0.86, P = 0.01). The recipient G/G or A/G genotype was associated with a better OS (adjusted HR, 0.68; 95% CI, 0.47-0.99; P = 0.05) and a trend toward a reduced TRM (adjusted HR, 0.61; 95% CI, 0.35-1.06; P = 0.08). Granzyme B polymorphism did not have any effect on the transplant outcomes in patients with lymphoid malignancies consisting of acute lymphoid leukemia and malignant lymphoma. These data suggest that there is an association between the granzyme B genotype and better clinical outcomes in patients with myeloid malignancies after unrelated BMT. |
| format |
article |
| author |
Luis J Espinoza Akiyoshi Takami Katsuya Nakata Kayoko Yamada Makoto Onizuka Takakazu Kawase Hiroshi Sao Hideki Akiyama Koichi Miyamura Shinichiro Okamoto Masami Inoue Takahiro Fukuda Yasuo Morishima Yoshihisa Kodera Shinji Nakao Japan Marrow Donor Program |
| author_facet |
Luis J Espinoza Akiyoshi Takami Katsuya Nakata Kayoko Yamada Makoto Onizuka Takakazu Kawase Hiroshi Sao Hideki Akiyama Koichi Miyamura Shinichiro Okamoto Masami Inoue Takahiro Fukuda Yasuo Morishima Yoshihisa Kodera Shinji Nakao Japan Marrow Donor Program |
| author_sort |
Luis J Espinoza |
| title |
Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. |
| title_short |
Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. |
| title_full |
Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. |
| title_fullStr |
Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. |
| title_full_unstemmed |
Genetic variants of human granzyme B predict transplant outcomes after HLA matched unrelated bone marrow transplantation for myeloid malignancies. |
| title_sort |
genetic variants of human granzyme b predict transplant outcomes after hla matched unrelated bone marrow transplantation for myeloid malignancies. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2011 |
| url |
https://doaj.org/article/49226eb624d5478481b10abfd0135fdc |
| work_keys_str_mv |
AT luisjespinoza geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT akiyoshitakami geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT katsuyanakata geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT kayokoyamada geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT makotoonizuka geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT takakazukawase geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT hiroshisao geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT hidekiakiyama geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT koichimiyamura geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT shinichirookamoto geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT masamiinoue geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT takahirofukuda geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT yasuomorishima geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT yoshihisakodera geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT shinjinakao geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies AT japanmarrowdonorprogram geneticvariantsofhumangranzymebpredicttransplantoutcomesafterhlamatchedunrelatedbonemarrowtransplantationformyeloidmalignancies |
| _version_ |
1718424411446444032 |